Skip to main content
Year archive

NeopharmCO.,LTD. — 2022 filings

All 17 regulatory filings released by NeopharmCO.,LTD. (092730) in 2022, sourced directly from the official regulator.

17 Filings
2022 Period
2022 filings (17)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2022-12-09 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-11 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q3 2022
2022-11-04 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-12 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q2 2022
2022-08-05 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-13 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2022
2022-05-06 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount
2022-04-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-24 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-16 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-10 Korean
주주총회소집공고
AGM Information
2022-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-08 Korean
주주총회소집결의
AGM Information
2022-03-02 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2021
2022-02-08 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-02-08 Korean